References
- Dick AD, Tundia N, Sorg R, et al. Risk of ocular complications in patients with noninfectious intermediate uveitis, posterior uveitis, or panuveitis. Ophthalmology 2016;123(3):655–662.
- Venkatesh P, Gogia V, Shah B, et al. Patterns of uveitis at the Apex Institute for Eye Care in India: results from a prospectively enrolled patient data base (2011–2013). Int Ophthalmol 2016;36(3):365–372.
- Jabs DA, Nussenblatt RB, Rosenbaum JT, for the Standardization of Uveitis Nomenclature Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 2005;140(3):509–516.
- Rodriguez M, Siva A, Cross SA, et al. Optic neuritis: a population-based study in Olmsted County, Minnesota. Neurology 1995;45(2):244–250.
- Marques IB, Matias F, Silva ED, et al. Risk of multiple sclerosis after optic neuritis in patients with normal baseline brain MRI. J Clin Neurosci 2014;21(4):583–586.
- Jakob E, Reuland MS, Mackensen F, et al. Uveitis subtypes in a German interdisciplinary uveitis center – analysis of 1916 patients. J Rheumatol 2009;36(1):127–136.
- Smith JR, Rosenbaum JT. Neurological concomitants of uveitis. Br J Ophthalmol 2004;88(12):1498–1499.
- Boskovich SA, Lowder CY, Meisler DM, Gutman FA. Systemic diseases associated with intermediate uveitis. Cleve Clin J Med 1993;60(6):460–465.
- Malinowski SM, Pulido JS, Folk JC. Long-term visual outcome and complications associated with pars planitis. Ophthalmology 1993;100(6):818–824; discussion 825.
- Raja SC, Jabs DA, Dunn JP, et al. Pars planitis: clinical features and class II HLA associations. Ophthalmology 1999;106(3):594–599
- Martinez-Lapiscina EH, Fraga-Pumar E, Pastor X, et al. Is the incidence of optic neuritis rising? Evidence from an epidemiological study in Barcelona (Spain), 2008-2012. J Neurol 2014;261(4):759–767